HealthLynked to Premier 'Forever: The End of Aging' Medical Documentary at CMX CinéBistro Theater in Naples, Florida on August 28th
05 Aug 2022
Cell TherapyAcquisition
HealthLynked to Premier 'Forever: The End of Aging' Medical Documentary at CMX CinéBistro Theater in Naples, Florida on August 28th
NAPLES, Fla., Aug. 5, 2022 /PRNewswire/ -- HealthLynked Corp. (OTCQB: HLYK), ("HealthLynked" or the "Company") a global healthcare network focused on care management of its members and a provider of healthcare technologies that connect doctors, patients, and medical data, today announced it will be hosting a onetime screening of the documentary 'Forever: The End of Aging' at CMX CinéBistro theater on August 28th at 7 pm.
CMX CinéBistro is located at the Coastland Mall at 2000 9th St N, Naples, FL 34103. Tickets can be requested online at: https://foreverendofagingmovie.com/ or by calling 1-239-799-7116. Seating is limited for this premier screening.
'Forever' was written and directed by award-winning film and television writer Paul Castro, writer of the original screenplay 'August Rush.'
The film interviews experts from medical specialties including genomics, cancer diagnostics, artificial intelligence, machine learning, functional and regenerative medicine, and stem cell therapies, while exploring how these technologies are advancing medical treatments that could significantly impact our health and how long we will live.
The film features medical experts from around the country including:
Bob Gasparini – Cancer Genetics; Former President, NeoGenomics Laboratories
Michael Dent, M.D. – CEO of HealthLynked Patient Information Network
Chadwick Prodromos, M.D. – Stem Cell Therapy
Robert Mino, J.D. – Healthcare Patent Attorney
David Perlmutter, M.D. – Neurologist and Bestselling Author of 'Grain Brain' and 'Drop Acid'
Pam Hughes, D.O. – Functional Medicine and Nutritional Expert
Edwardo Maristany, M.D. – Functional Medicine, Genetic Testing, and Hyperbaric Medicine
Arnold Pallay, M.D. – Clinical Application of Genetic Testing
Randy Miller, M.D. – Cosmetic Surgeon
Ryan Smith – Founder of Tru Diagnostics
Robert Marx, DDS FACS- Facial Reconstruction
Jonathan Jay, M.D. - Urologist
Sharon Hausman-Cohen, M.D. – Harvard Trained Expert in Medical Genetics
Dr. Larry Antonucci – CEO of Lee Healthcare System
Learn more about 'Forever: The End of Aging' at: https://www.imdb.com/title/tt19296904/
HealthLynked, along with its innovative technologies that improve communication between patients and doctors, is featured in the movie to demonstrate how individuals can participate in medical discoveries through information sharing. Hereditary medical conditions such as cancer, diabetes, and heart disease are caused by lifestyle and genetic factors. In "Forever," HealthLynked will discuss the power of data in determining the roles each of these play in diseases and how this information can lead to improved healthcare for everyone.
Dr. Michael Dent, Chairman and Chief Executive Officer, stated "HealthLynked is excited to host the premier viewing of 'Forever: The End of Aging.' We are hopeful that the documentary will be picked up by an online streaming service so that a larger audience can learn more about how HealthLynked is working to advance healthcare through the efficient change of healthcare information. We are hopeful that one day medical conditions such as cancer, neurodegenerative diseases, diabetes, and even aging will be a thing of the past."
The HealthLynked app is available for download on both iOS and Android devices.
Android
About CMX CinéBistro
CMX Cinemas opened its first flagship dine-in theatre in April 2017 at Brickell City Centre, Miami, FL, ushering in a new era of luxury movie-going experiences. CMX provides state-of-the-art technology and luxurious reclining leather seats, that can be enjoyed through different types of experiences including: CMX CinéBistro, the luxury dine-in theatre concept with in-seat service featuring modern, rustic New-American cuisine from classically trained chefs, CMX Market Cinemas, a gourmet grab-and-go culinary and movie experience, and CMX Cinemas, the upgraded traditional theater with classic concessions.
About HealthLynked Corp.
HealthLynked Corp. provides a solution for both patient members and providers to improve healthcare through the efficient exchange of medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take more control of their healthcare. Members enter their medical information, including medications, allergies, past surgeries, and personal health records, in one convenient online and secure location, free of charge. Participating healthcare providers can connect with their current and future patients through the system. Benefits to in-network providers include the ability to utilize the HealthLynked patent-pending patient access hub "PAH" for patient analytics. Other benefits for preferred providers include HLYK marketing tools to connect with their active and inactive patients to improve patient retention, access more accurate and current patient information, provide more efficient online scheduling, and to fill last-minute cancelations using the Company's "real-time appointment scheduling" all within its mobile application. Preferred providers pay a monthly fee to access these HealthLynked services. For additional information about HealthLynked Corp., please visit www.healthlynked.com and connect with HealthLynked on Twitter, Facebook, Instagram, and LinkedIn.
Forward-Looking Statements
Forward-Looking Statements in this press release, which are not historical facts, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Our actual results, including as a result of any acquisitions, performance, or achievements may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "predict," "potential," "continue," "likely," "will," "would" and variations of these terms and similar expressions, or the negative of these terms or similar expressions. Such forward-looking statements are necessarily based upon estimates and assumptions that, while considered reasonable by our management, and us are inherently uncertain. We caution you not to place undue reliance on any forward-looking statements, which are made as of the date of this press release. We undertake no obligation to update publicly any of these forward-looking statements to reflect actual results, new information or future events, changes in assumptions or changes in other factors affecting forward-looking statements, except to the extent required by applicable laws. If we update one or more forward-looking statements, no inference should be drawn that we will make additional updates with respect to those or other forward-looking statements. Certain risks and uncertainties applicable to our operations and us are described in the "Risk Factors" section of our most recent Annual Report on Form 10-K and in other filings we have made with the U.S. Securities and Exchange Commission. These reports are publicly available at www.sec.gov.
HLYK Contact:
George O'Leary
Chief Financial Officer
[email protected]
(800)-928-7144, ext. 103
William Hayde
Capital Markets Strategist
[email protected]
(631)-403-4337
SOURCE HealthLynked Corp.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.